Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM
Verve Therapeutics Fail-to-Deliver
Total FTD Shares
1.48K
Below Average
FTD / Avg. Volume
0.03%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 9, 2025,
Verve Therapeutics Inc. has
1,484
shares failed to deliver, representing 0.03%
of the average daily volume of
5,716,259
shares. Over the past year, the monthly average FTD is
22,061
shares, with the current level 93% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 09, 2025 | 11.09 | 1.48K | -97.13% |
Jun 30, 2025 | 11.23 | 51.67K | -76.56% |
May 23, 2025 | 4.36 | 220.43K | +7933.09% |
Apr 30, 2025 | 5.67 | 2.74K | +174.40% |
Mar 26, 2025 | 5.4 | 1K | +1438.46% |
Feb 28, 2025 | 6.33 | 65 | +261.11% |
Jan 30, 2025 | 7.41 | 18 | -99.22% |
Dec 30, 2024 | 5.54 | 2.32K | +38.27% |
Nov 26, 2024 | 5.31 | 1.68K | +675.46% |
Oct 31, 2024 | 5.73 | 216 | -99.88% |
Sep 27, 2024 | 4.98 | 184.93K | +23823.16% |
Aug 30, 2024 | 6.7 | 773 | +680.81% |
Jul 30, 2024 | 7.02 | 99 | -82.84% |
Jun 28, 2024 | 4.88 | 577 | +143.46% |
May 31, 2024 | 5.19 | 237 | -99.84% |
Apr 29, 2024 | 6.26 | 145.9K | +717.48% |
Mar 28, 2024 | 13.28 | 17.85K | +325.97% |
Feb 28, 2024 | 17.96 | 4.19K | -85.59% |
Jan 29, 2024 | 11.99 | 29.07K | +103739.29% |
Dec 28, 2023 | 14.95 | 28 | -98.12% |
Nov 29, 2023 | 11.2 | 1.49K | -95.86% |
Oct 31, 2023 | 12.04 | 35.96K | +4160.90% |
Sep 29, 2023 | 13.26 | 844 | -84.71% |
Aug 14, 2023 | 17.07 | 5.52K | +1380.16% |
Jul 31, 2023 | 20.49 | 373 | +239.09% |
Jun 29, 2023 | 18.77 | 110 | -72.50% |
May 26, 2023 | 15.99 | 400 | -97.99% |
Apr 28, 2023 | 15.93 | 19.93K | +10973.89% |
Mar 31, 2023 | 14.42 | 180 | -70.05% |
Feb 27, 2023 | 18.93 | 601 | +6577.78% |
Jan 31, 2023 | 22.75 | 9 | n/a |